DR. C. TUNA LUMI RADIANCE BRIGHTENING CREAM 22 SPF- octocrylene, octinoxate, avobenzone kit

Dr. C. Tuna Lumi Radiance Brightening Cream 22 SPF by

Drug Labeling and Warnings

Dr. C. Tuna Lumi Radiance Brightening Cream 22 SPF by is a Otc medication manufactured, distributed, or labeled by Farmasi US LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

ACTIVE INGREDIENT

Octocrylene 5.5%

Ethylhexyl Methoxycinnamate 6%

Butyl Methoxydibenzoylmethane 2%

PURPOSE

Sunscreen

USE

Helps maintain bright skins and balance uneven skin tone with regular use.

WARNINGS

For external use only. Avoid contact with eyes. If contact occurs rinse thoroughly with water.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

Recommended to use twice a day.

INACTIVE INGREDIENTS:

Water/Aqua, Cetearyl Alcohol, Stearic Acid, Mineral Oil / Paraffinum Liquidum, Isopropyl Myristate, Glycerin, Titanium Dioxide, Ceteareth-20,  Ceteareth-12, Cetearyl Alcohol, Cetyl Palmitate, Glyceryl Stearate, Butylene Glycol, Silica, Ammonium Polyacrylate, Hydrolyzed Algae Extract, Pancratium Maritimum Extract, Dimethicone, Phenoxyethanol, Fragrance / Parfum, Niacinamide, Triethanolamine, Ethylhexylglycerin, Tocopheryl Acetate.

Package Labeling:

INGREDIENTS AND APPEARANCE

DR. C. TUNA LUMI RADIANCE BRIGHTENING CREAM 22 SPF 
octocrylene, octinoxate, avobenzone kit

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 74690-023

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 74690-023-00	1 in 1 KIT	08/15/2021

Quantity of Parts
Part #	Package Quantity	Total Product Quantity
Part 1	1 PACKET	2.5 mL

Part 1 of 1

DR. C. TUNA LUMI RADIANCE BRIGHTENING CREAM 22 SPF 
octocrylene, octinoxate, avobenzone cream

Product Information
Item Code (Source)	NDC: 74690-024
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM)	OCTOCRYLENE	55 mg  in 1 mL
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	60 mg  in 1 mL
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX)	AVOBENZONE	20 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
STEARIC ACID (UNII: 4ELV7Z65AP)
MINERAL OIL (UNII: T5L8T28FGP)
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)
GLYCERIN (UNII: PDC6A3C0OX)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY)
CETEARETH-12 (UNII: 7V4MR24V5P)
CETYL PALMITATE (UNII: 5ZA2S6B08X)
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
DIMETHICONE (UNII: 92RU3N3Y1O)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
NIACINAMIDE (UNII: 25X51I8RD4)
TROLAMINE (UNII: 9O3K93S3TK)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 74690-024-00	2.5 mL in 1 PACKET; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	08/15/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	08/15/2021

Labeler - Farmasi US LLC (113303351)